Cargando…

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) developing in the context of preexisting cirrhosis is characterized by impaired autophagy that results in increased exosome release. This study was conducted to determine whether circulating exosomes expressing glypican 3 (GPC3) could be utilized a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aydin, Yucel, Koksal, Ali Riza, Thevenot, Paul, Chava, Srinivas, Heidari, Zahra, Lin, Dong, Sandow, Tyler, Moroz, Krzysztof, Parsi, Mansour A, Scott, John, Cohen, Ari, Dash, Srikanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671108/ https://www.ncbi.nlm.nih.gov/pubmed/34917553 http://dx.doi.org/10.2147/JHC.S327339

Ejemplares similares

Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles
por: Koksal, Ali Riza, et al.
Publicado: (2022)

A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis
por: Koksal, Ali Riza, et al.
Publicado: (2023)

Extracellular Vesicle Release Promotes Viral Replication during Persistent HCV Infection
por: Aydin, Yucel, et al.
Publicado: (2021)

Chaperone-Mediated Autophagy in the Liver: Good or Bad?
por: Dash, Srikanta, et al.
Publicado: (2019)

Targeting ER stress/PKA/GSK-3β/β-catenin pathway as a potential novel strategy for hepatitis C virus-infected patients
por: Lin, Dong, et al.
Publicado: (2023)

Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma
por: Chava, Srinivas, et al.
Publicado: (2017)

Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response
por: Dash, Srikanta, et al.
Publicado: (2016)

Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture
por: Aydin, Yucel, et al.
Publicado: (2017)

Retraction Note: Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture
por: Aydin, Yucel, et al.
Publicado: (2021)

Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients
por: Lin, Dong, et al.
Publicado: (2021)

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis [Corrigendum]
Publicado: (2022)

Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression
por: Aydin, Yucel, et al.
Publicado: (2019)

Interferon‐alpha‐induced hepatitis C virus clearance restores p53 tumor suppressor more than direct‐acting antivirals
por: Aydin, Yucel, et al.
Publicado: (2017)

Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response
por: Dash, Srikanta, et al.
Publicado: (2016)

Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy
por: Núñez, Kelley G., et al.
Publicado: (2022)

Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates
por: Núñez, Kelley G., et al.
Publicado: (2022)

PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival
por: Núñez, Kelley G., et al.
Publicado: (2021)

Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis
por: Koksal, Deniz, et al.
Publicado: (2016)

Glypicans
por: Filmus, Jorge, et al.
Publicado: (2008)

Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
por: Núñez, Kelley G., et al.
Publicado: (2021)

Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
por: Dash, Srikanta, et al.
Publicado: (2020)

Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
por: Frampton, Adam E., et al.
Publicado: (2018)

A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
por: Lai, Xianyin, et al.
Publicado: (2017)

Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma
por: Zhao, Juan, et al.
Publicado: (2022)

Expression of Glypican 3 in low and high grade urothelial carcinomas
por: Aydin, Oguz, et al.
Publicado: (2015)

Safety of ERCP in patients with liver cirrhosis: a national database study
por: Navaneethan, Udayakumar, et al.
Publicado: (2017)

Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes
por: Rahbari, Mohammad, et al.
Publicado: (2019)

Glypican-3, Vascular Endothelial Growth Factor and Golgi Protein-73 for Differentiation between Liver Cirrhosis and Hepatocellular Carcinoma
por: Mamdouh, Samah, et al.
Publicado: (2023)

Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture
por: Kurt, Ramazan, et al.
Publicado: (2015)

Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities
por: Moutinho-Ribeiro, Pedro, et al.
Publicado: (2022)

Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis
por: Chandra, Partha K., et al.
Publicado: (2014)

Cancer immunotherapy‐targeted glypican‐3 or neoantigens
por: Shimizu, Yasuhiro, et al.
Publicado: (2018)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

Glypican 3 as a Serum Marker for Hepatoblastoma
por: Zhou, Shengmei, et al.
Publicado: (2017)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019)

Glypicans and cytonemes unite to distribute Wnt ligands
por: Waghmare, Indrayani, et al.
Publicado: (2021)

Neuroendocrine Tumors Show Altered Expression of Chondroitin Sulfate, Glypican 1, Glypican 5, and Syndecan 2 Depending on Their Differentiation Grade
por: García-Suárez, Olivia, et al.
Publicado: (2014)

The Glypican-1/HGF/C-Met and Glypican-1/VEGF/VEGFR2 Ternary Complexes Regulate Hair Follicle Angiogenesis
por: Colin-Pierre, Charlie, et al.
Publicado: (2021)

Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity
por: Moudi, Bita, et al.
Publicado: (2018)

Glypican and Biglycan in the Nuclei of Neurons and Glioma Cells: Presence of Functional Nuclear Localization Signals and Dynamic Changes in Glypican During the Cell Cycle
por: Liang, Yu, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_slvr0lmclmm4ugek6thc9hoart